278 related articles for article (PubMed ID: 8023751)
1. Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli.
O'Daly JA; Carrasco H; Fernandez V; Rodríguez MB
Acta Trop; 1994 Apr; 56(4):265-87. PubMed ID: 8023751
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
Saldaña A; Sousa OE
J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactivity studies and differential serodiagnosis of human infections caused by Trypanosoma cruzi and Leishmania spp; use of immunoblotting and ELISA with a purified antigen (Ag163B6).
Malchiodi EL; Chiaramonte MG; Taranto NJ; Zwirner NW; Margni RA
Clin Exp Immunol; 1994 Sep; 97(3):417-23. PubMed ID: 8082296
[TBL] [Abstract][Full Text] [Related]
4. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.
Flechas ID; Cuellar A; Cucunubá ZM; Rosas F; Velasco V; Steindel M; Thomas Mdel C; López MC; González JM; Puerta CJ
BMC Infect Dis; 2009 Nov; 9():186. PubMed ID: 19939275
[TBL] [Abstract][Full Text] [Related]
5. Immunoparasitological studies of Trypanosoma cruzi low virulence clones from Panama: humoral immune responses and antigenic cross-reactions with Trypanosoma rangeli in experimentally infected mice.
Saldaña A; Sousa OE; Orn A
Scand J Immunol; 1995 Dec; 42(6):644-50. PubMed ID: 8552988
[TBL] [Abstract][Full Text] [Related]
6. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by sera from Chagas' disease patients: prognosis value in Chagas disease.
Laucella SA; de Titto EH; Segura EL
Acta Trop; 1996 Dec; 62(3):151-62. PubMed ID: 9025983
[TBL] [Abstract][Full Text] [Related]
7. Identification of immunodominant antigens in Mexican strains of Trypanosoma cruzi.
Bucio MI; Cabrera M; Segura EL; Zenteno E; Salazar-Schettino M
Immunol Invest; 1999 Jul; 28(4):257-68. PubMed ID: 10454003
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies in sera from Chagas' disease patients using a Trypanosoma cruzi immunodominant recombinant antigen.
Paranhos-Bacalla GS; Santos MR; Cotrim PC; Rassi A; Jolivet M; Camargo ME; Da Silveira JF
Parasite Immunol; 1994 Mar; 16(3):165-9. PubMed ID: 8208589
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection.
Marini V; Moretti E; Bermejo D; Basso B
Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):32-7. PubMed ID: 21340352
[TBL] [Abstract][Full Text] [Related]
10. Antigenic significance of a Trypanosoma rangeli sialidase.
Saldaña A; Harris RA; Orn A; Monroy C; Ortega-Barria E; Sousa OE
J Parasitol; 2002 Aug; 88(4):697-701. PubMed ID: 12197116
[TBL] [Abstract][Full Text] [Related]
11. Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens.
Sánchez B; Monteón V; Reyes PA; Espinoza B
Arch Med Res; 2001; 32(5):382-8. PubMed ID: 11578752
[TBL] [Abstract][Full Text] [Related]
12. Immune response and Trypanosoma cruzi infection in Trypanosoma rangeli-immunized mice.
Basso B; Moretti ER; Vottero-Cima E
Am J Trop Med Hyg; 1991 Apr; 44(4):413-9. PubMed ID: 1828328
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Trypanosoma cruzi antigens recognized by sera from patients with chronic Chagas' disease.
Gea S; Rodriguez P; Vottero-Cima E
Int Arch Allergy Appl Immunol; 1987; 84(4):410-3. PubMed ID: 3119504
[TBL] [Abstract][Full Text] [Related]
14. [Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis].
De Lima Rivero AR; Farías Tamoy MN; Tortolero Leal E; Navarro Aguilera MC; Contreras Alvarez VT
Acta Cient Venez; 2001; 52(4):235-47. PubMed ID: 11915441
[TBL] [Abstract][Full Text] [Related]
15. Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.
Gea S; Ordonez P; Cerban F; Iosa D; Chizzolini C; Vottero-Cima E
Am J Trop Med Hyg; 1993 Nov; 49(5):581-8. PubMed ID: 7504407
[TBL] [Abstract][Full Text] [Related]
16. Immuno-enzymatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: a tool for epidemiological studies.
Cimino RO; Rumi MM; Ragone P; Lauthier J; D'Amato AA; Quiroga IR; Gil JF; Cajal SP; Acosta N; Juárez M; Krolewiecki A; Orellana V; Zacca R; Marcipar I; Diosque P; Nasser JR
Parasitology; 2011 Jul; 138(8):995-1002. PubMed ID: 21518468
[TBL] [Abstract][Full Text] [Related]
17. Clinical Trypanosoma rangeli infection as a complication of Chagas' disease.
Guhl F; Hudson L; Marinkelle CJ; Jaramillo CA; Bridge D
Parasitology; 1987 Jun; 94 ( Pt 3)():475-84. PubMed ID: 2441341
[TBL] [Abstract][Full Text] [Related]
18. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
Basso B; Marini V
Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
[TBL] [Abstract][Full Text] [Related]
19. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
Yokoyama-Yasunaka JK; Piazza RM; Umezawa ES; Stolf AM
J Clin Lab Anal; 1998; 12(2):108-14. PubMed ID: 9524295
[TBL] [Abstract][Full Text] [Related]
20. Expression in Escherichia coli of a dominant immunogen of Trypanosoma cruzi recognized by human chagasic sera.
Cotrim PC; Paranhos GS; Mortara RA; Wanderley J; Rassi A; Camargo ME; da Silveira JF
J Clin Microbiol; 1990 Mar; 28(3):519-24. PubMed ID: 1691209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
